Publications

Evidence of our team's scientific rigour and commitment to medical advancement can be found in our extensive library of Niche Publications. We believe that sharing the results of our collaborative research is essential for fostering innovation and improving patient outcomes.

This resource brings together our peer reviewed papers, conference presentations, and technical posters, showcasing our deep expertise across a broad range of therapeutic areas from cardiovascular endocrinology to complex frailty studies. By making our published work accessible, we aim to contribute to the global scientific dialogue and provide our partners with a transparent look at the high standard clinical and analytical thinking that underpins every Niche project.

Explore our bibliography to see how we are helping to shape the future of medicine.

Acknowledged Publications

Recognised contributions to world-class research

A selection of peer-reviewed publications where Niche's scientific and clinical expertise has been formally acknowledged by research teams worldwide, reflecting the breadth and depth of our contribution to advancing medical knowledge.

Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial

Written by

Reid HM, Maginn M, Perkins CM, Mulvaney EP, Boyce M, Yamamoto T, Kinsella BT.

Explore The Publication

Multidisciplinary paper on patient blood management in cardiothoracic surgery in the UK: perspectives on practice during COVID-19

Written by

Al-Attar N, Gaer J, Giordano V, Harris E, Kirk A, Loubani M, Meybohm P, Sayeed R, Stock U, Travers J, Whiteman B.

Explore The Publication

1 2 3 … 58 Next »

Niche Manuscripts

Where our words shape the science

Publications where the Niche medical writing team played a central role in crafting the manuscript itself — translating complex clinical data into clear, compelling and submission-ready scientific communications.

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges

Written by

Mundy C, Bush J, Cheriyan J, Lorch U, Stringer S, Taubel J, Wydenbach K, Hardman TC.

Explore The Publication

The future of clinical trials and drug development: 2050

Written by

Hardman TC, Aitchison R, Scaife R, Edwards J, Slater G.

Explore The Publication

1 2 3 … 47 Next »

Publications

Acknowledged Publications

Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial

Multidisciplinary paper on patient blood management in cardiothoracic surgery in the UK: perspectives on practice during COVID-19

Niche Manuscripts

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges

The future of clinical trials and drug development: 2050

Hi ✋